Lupin Settles With Apotex Over Cholesterol Drug Patents

Law360, New York (July 14, 2011, 8:06 PM EDT) -- Lupin Atlantis Holdings SA settled with Apotex Inc., Apotex Corp. and Ethypharm SA on Thursday in a patent suit in New York in which Lupin sought to block the manufacture of a generic version of cholesterol drug Antara.

U.S. District Judge Jed S. Rakoff signed off on the settlement Thursday, two days after the parties filed a stipulation of dismissal notifying the court that an agreement had been reached. Settlement details were unavailable.

The settlement is the second among Lupin's patent suits over fenofibrate, the active...
To view the full article, register now.